Compare MXCT & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | CURV |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.0M | 159.2M |
| IPO Year | 2021 | 2021 |
| Metric | MXCT | CURV |
|---|---|---|
| Price | $1.19 | $1.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $5.50 | $1.59 |
| AVG Volume (30 Days) | ★ 1.4M | 602.9K |
| Earning Date | 05-12-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $33,026,000.00 | ★ $1,000,092,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.50 | $1.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $0.94 |
| 52 Week High | $2.37 | $3.01 |
| Indicator | MXCT | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 48.50 |
| Support Level | $1.08 | $1.03 |
| Resistance Level | $1.30 | $1.93 |
| Average True Range (ATR) | 0.07 | 0.18 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 46.40 | 29.23 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.